Not content with taking on the respiratory syncytial virus (RSV) prevention market with its antibody-based therapy Beyfortus, AstraZeneca has agreed to buy US biotech Icosavax and its phase 3-ready ...
The EMA's human medicines committee has recommended approval for Bavarian Nordic's chikungunya vaccine, which is shaping up to be the first alternative to a rival shot from Valneva. The CHIKV VLP ...
Abstract: Time Difference of Arrival (TDoA) based Visible Light Positioning (VLP) and Optical Wireless Positioning (OWP) offer considerable potential over conventional Received Signal Strength (RSS) ...
[ICCV 2025] A PyTorch official implementation for One Perturbation is Enough: On Generating Universal Adversarial Perturbations against Vision-Language Pre-training Models. Below we provide running ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results